The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide

Journal of Human Hypertension

Volumn 11, Issue 8, 1997, Pages 477-481

  Punzi, H A ^a   Novrit, B A ^b  

^a Trinity Medical Center   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Black patients; Blood pressure; Hydrochlorothiazide; Severe hypertension; Trandolapril; Verapamil

Indexed keywords

HYDROCHLOROTHIAZIDE; TRANDOLAPRIL; VERAPAMIL;

ADULT; AGED; ARTHRALGIA; ARTICLE; CAUCASIAN; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; IMPOTENCE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEGRO; RACE DIFFERENCE; SEQUENTIAL ANALYSIS; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; SUPINE POSITION; SUSTAINED RELEASE FORMULATION; SWEATING; THORAX PAIN; TREATMENT OUTCOME; VERTIGO; VOMITING;

EID: 0030874704     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000439     Document Type: Article

References (13)

1. White WB, Viaderi JJ, Lane TJ, Podesla S. Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther 1986; 39: 43-48.
2. Singer DRG, Markander ND, Shore AC, MacGregor GA. Captopril and nifedipine in combination for moderate to severe essential hypertension. Hypertension 1987; 9: 629-633.
3. Levine JH et al. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. Am J Hypertens 1995; 8: 494-499.
4. Williams GH. Medical Intelligence. Drug Therapy. Converting enzyme inhibitors in the treatment of hypertension. N Engl J Med 1988; 319 (23): 1517-1525.
5. Skoularigis J et al. Nifedipine versus captopril in the management of moderate hypertension in black patients. Am J Hypertens 1994; 7: 440-447.
6. Weir MR, Saunders E and the Trandolapril Multicenter Study Group. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensives. Hypertension 1995; 26: 124-130.
7. Cubeddu LX et al. A comparison of verapamil and propranolol for the initial treatment of hypertension: Racial differences in response. JAMA 1986; 256: 2214-2221.
8. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild to moderate hypertensive patients. J Cardiovasc Pharmacol 1985; 7 (Suppl 1): S52-S55.
9. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol 1982; 14: S97-S101.
10. Goldstein RJ. The treatment of moderate to severe hypertension with ACE inhibitors. J Cardiovasc Pharmacol 1990; 15(Suppl 2): S29-S35.
11. Wolfson P, Abernethy D, DiPette DJ, Suzman R. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension. Am J Cardiol 1988; 62: 103G-108G.
12. Frishman WH et al. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: A randomized, double-blind, placebo-controlled, parallel group study. J Clin Pharmacol 1995; 35: 1060-1066.
13. Mancia G et al. Effect of verapamil (v), trandolapril (t) and their fixed combination (vt) on 24 hour blood pressure: The Veratran Study. J Hypertens 1996; 14 (Suppl 1): S231.